Population pharmacokinetic model with time‐varying clearance for lorlatinib using pooled data from patients with non‐small cell lung cancer and healthy participants

by Joseph Chen, Brett Houk, Yazdi K. Pithavala, Ana Ruiz‐Garcia
Published 2021-02-01

Pharmacokinetic Models to Characterize the Absorption Phase and the Influence of a Proton Pump Inhibitor on the Overall Exposure of Dacomitinib

by Ana Ruiz-Garcia, Weiwei Tan, Jerry Li, May Haughey, Joanna Masters, Jennifer Hibma, Swan Lin
Published 2020-04-01

Characterization of the Relationship of Inotuzumab Ozogamicin Exposure With Efficacy and Safety End Points in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia

by Joseph Chen, May Haughey, Erik Vandendries, Daniel J. DeAngelo, Hagop M. Kantarjian, Ana Ruiz‐Garcia
Published 2021-01-01